| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
1
| 2
| 3
| 4
| 5
| 6
| 7
|
NEXT 
|
| Title |
Date |
Price |
|
The increasing importance of biotechnology and its application in the development of new medicines has driven the industry forward in 2000. However, 2000 was a tough year for the smaller companies that... |
Jan, 2001 |
€1 605 |
|
This market brief looks at the evolving computer and IT systems that are being applied to drug discovery to speed time to market. How can you benefit from this report? * Assess the impact of IT developments... |
Jan, 2001 |
€2 033 |
|
Scientific and Medical Journals on the Web has evolved since 1998. Originally, it addressed whether or not Scientific, Technical and Medical (STM) publishers needed to have an online version of their journal,... |
Mar, 2005 |
€1 926 |
|
Sales reps are a vital part of a life science supplier's success because they provide a direct link to their customers. Based on a 34-question survey of over 1,800 scientists, the second edition of Improving... |
Jan, 2005 |
€2 033 |
|
The GPC Biotech AG Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The GTC Biotherapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The GTX INC/TN Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The GW Pharmaceuticals PLC Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The H.Lundbeck AS Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Halozyme Therapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The HealthWatch Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
The Helix BioMedix Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The HemaCare Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Oct, 2006 |
€375 |
|
The Hemagen Diagnostics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Mar, 2006 |
€375 |
|
As a country, India offers some significant competitive advantages in the area of Biotechnology such as low-cost technology in clinical trials, R&D, molecule synthesis and fine chemical production. The... |
Jan, 2001 |
€139 |
|
The Hemispherx Biopharma Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Hemosol Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Heska Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Hi-Tech Pharmacal Co Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Hollis-Eden Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Jan, 2007 |
€375 |
|
|
|
| Biotechnology Market News |
03.06.2010 / The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
GBI Research, the leading business intelligence provider, has released its latest research “ The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis. ” The report...
17.05.2010 / The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact
The global diabetes care devices market was valued at $10.9 billion in 2009. The market is expected to continue with an increased growth over the next seven years to reach $18 billion in 2016 with a forecast Compounded Annual Growth Rate...
14.05.2010 / NicOx: FDA Panel’s Negative Opinion Casts Future of Osteoarthritis Drug Into Doubt
The FDA advisory committee has issued a negative recommendation for NicOx's naproxcinod.
FDA advisory meeting has voted 16 to one against recommending the potential osteoarthritis drug naproxcinod. The decision comes after the panel...
07.05.2010 / Dendreon: Landmark Cancer Vaccine Approval but High Costs May Hinder Uptake
Having been approved by the FDA in castration-resistant prostate cancer, Dendreon's Provenge represents the first therapeutic cancer vaccine to reach the market. This is a significant step forward: the current standard of care is Taxotere-based...
23.04.2010 / Explosion of Opportunities in Nutraceuticals
New research* from Business Insights has revealed that despite costs of over $10m to gain the right to claim that a food or drink product has a health benefit, investing is worthwhile.
Research from the independent business analyst has...
23.04.2010 / AAN 2010: New Treatments Address Unmet Needs in Alzheimer's and Epilepsy
A number of leading drug makers used this year's meeting of the American Academy of Neurology to present new data for promising pipeline candidates. Despite promising results, however, Datamonitor believes that the epilepsy drugs will struggle to...
13.04.2010 / Glaucoma - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist’s new report, “ Glaucoma - Drug Pipeline Analysis and Market Forecasts to 2016 ” is an essential source of information and analysis on the global Glaucoma market. The report...
13.04.2010 / Irritable Bowel Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist, has released a new report, “ Irritable Bowel Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 ”. The report is an essential source of information and analysis on the global...
12.02.2010 / Global Heart Valve Market 2008-2012
The lifestyle changes and, especially dietary habits, are leading to an increase in the incidences of cardiovascular diseases. These increasing incidences of cardiovascular diseases are one of the growth drivers of Heart Valves.
TechNavio...
09.02.2010 / China medical equipment market to grow due strong government initiatives, finds Netscribes
Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Medical Equipment Market in China 2010 report covering an industry which is expected to witness strong growth. China is the third largest...
|
|
|
